Search Within

Alexander Edward Drilon

  1. "Computational Oncology Service"
Formats
  1. Journal Article (12)
  2. Meeting Abstract (9)
Groups
  1. Computational Oncology Service (21)
  2. Department of Medicine (21)
  3. Epidemiology and Biostatistics (21)
  4. GSK Faculty (21)
  5. Solid Tumor Oncology Division (21)
  6. Thoracic Oncology (21)

More Groups

People
  1. Nikolaus Schultz (16)
  2. Marc Ladanyi (14)
  3. Debyani Chakravarty (13)
  4. Michael Berger (13)
  5. David Solit (11)
  6. Maria Arcila (11)

More People

Years
  1. 2025 (1)
  2. 2024 (3)
  3. 2023 (2)
  4. 2022 (5)
  5. 2021 (2)
  6. 2020 (1)

More Years

Publications
  1. Journal of Clinical Oncology (7)
  2. Cancer Discovery (3)
  3. Clinical Cancer Research (2)
  4. JCO Precision Oncology (2)
  5. Annals of Oncology (1)
  6. Cancer Research (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (9)
  2. American Association for Cancer Research (6)
  3. Oxford University Press (2)
  4. American Medical Association (1)
  5. Elsevier Ireland Ltd. (1)
  6. Elsevier Science, Inc. (1)

More Publishers

Results (21)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genetic ancestry-based differences in biomarker-based eligibility for precision oncology therapies
    Journal Article

    Arora, K.; Suehnholz, S. P.; Zhang, H.; Ostrovnaya, I.; Kundra, R.; Nandakumar, S.; Nissan, M. H.; Brannon, A. R.; Bandlamudi, C.; Ladanyi, M.; more...
    JAMA Oncology (2025)

    Fulltext@MSK | Save
  • OncoKB: Automated somatic variant classification for rapid clinical decision making
    Meeting Abstract

    Suehnholz, S.; Nissan, M.; Zhang, H.; Kundra, R.; Lu, C.; Dhaneshwar, A.; Fernandez, N.; Cavender, K.; Preiser, B.; Konecny, J.; more...
    Journal of Molecular Diagnostics (2024)

    Fulltext@MSK | Save
  • Tracking the FDA precision oncology drug approval landscape in OncoKB
    Meeting Abstract

    Suehnholz, S. P.; Kundra, R.; Zhang, H.; Nissan, M. H.; Lu, C.; Dhaneshwar, A.; Fernandez, N.; Nandakumar, S.; Arcila, M. E.; Ladanyi, M.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Quantifying the expanding landscape of clinical actionability for patients with cancer
    Journal Article

    Suehnholz, S. P.; Nissan, M. H.; Zhang, H.; Kundra, R.; Nandakumar, S.; Lu, C.; Carrero, S.; Dhaneshwar, A.; Fernandez, N.; Xu, B. W.; more...
    Cancer Discovery (2024)

    Fulltext@MSK | Save
  • Quantifying the growth of clinical actionability in precision oncology using OncoKB
    Meeting Abstract

    Suehnholz, S. P.; Kundra, R.; Nandakumar, S.; Nissan, M. H.; Zhang, H.; Lu, C.; Dhaneshwar, A.; Fernandez, N.; Carrero, S.; Arcila, M. E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Characterization of central nervous system clinico-genomic outcomes in ALK-positive non-small cell lung cancer patients with brain metastases treated with alectinib
    Journal Article

    Miao, E.; Eichholz, J. E.; Lebow, E. S.; Flynn, J.; Zhang, Z.; Walch, H.; Hubbeling, H.; Beal, K.; Moss, N. S.; Yu, K. K.; more...
    Lung Cancer (2023)

    Fulltext@MSK | Save
  • OncoKB, MSK's precision oncology knowledge base
    Meeting Abstract

    Suehnholz, S. P.; Nissan, M.; Zhang, H.; Kundra, R.; Lu, C.; Dhaneshwar, A.; Fernandez, N.; Carrero, S.; Arcila, M. E.; Ladanyi, M.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Genomic alterations in ALK fusion-positive non-small cell lung cancer (NSCLC) patients with brain metastases
    Meeting Abstract

    Eichholz, J.; Miao, E.; Lebow, E.; Walch, H.; Flynn, J.; Zhang, Z.; Hubbeling, H.; Beal, K.; Moss, N.; Yu, K.; more...
    Neuro-Oncology (2022)

    Fulltext@MSK | Save
  • Clinicopathologic characterization of ERK2 E322K mutation in solid tumors: Implications for treatment and drug development
    Meeting Abstract

    Liu, D.; Murciano-Goroff, Y. R.; Jee, J.; Arcila, M. E.; Buonocore, D. J.; Gao, J.; Chakravarty, D.; Schram, A. M.; Callahan, M. K.; Friedman, C. F.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Clinical outcomes of immune checkpoint inhibitors in HER2-amplified non-small cell lung cancers
    Meeting Abstract

    DeMatteo, R.; Goldman, D. A.; Lin, S. T.; Buonocore, D. J.; Gao, J.; Chang, J. C.; Rekhtman, N.; Offin, M.; Yu, H. A.; Isbell, J. M.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save